Parker RM, Copeland NG, Eyre HJ, Liu M, Gilbert DJ, Crawford J, Couzens M, Sutherland GR, Jenkins NA, Herzog H (2000). „Molecular cloning and characterisation of GPR74 a novel G-protein coupled receptor closest related to the Y-receptor family”. Brain Res. Mol. Brain Res. 77 (2): 199—208. PMID10837915. doi:10.1016/S0169-328X(00)00052-8.
Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Milligan G, Groarke DA, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM (2000). „Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor”. J. Biol. Chem. 275 (34): 25965—71. PMID10851242. doi:10.1074/jbc.M004515200.
Yang HY, Iadarola MJ (2006). „Modulatory roles of the NPFF system in pain mechanisms at the spinal level”. Peptides. 27 (5): 943—52. PMID16443306. doi:10.1016/j.peptides.2005.06.030.
Roumy M, Lorenzo C, Mazères S, Bouchet S, Zajac JM, Mollereau C (2007). „Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity”. The Journal of Biological Chemistry. 282 (11): 8332—42. PMID17224450. doi:10.1074/jbc.M606946200.
Yang HY, Tao T, Iadarola MJ (2008). „Modulatory role of neuropeptide FF system in nociception and opiate analgesia”. Neuropeptides. 42 (1): 1—18. PMID17854890. doi:10.1016/j.npep.2007.06.004.
Betourne A, Familiades J, Lacassagne L, Halley H, Cazales M, Ducommun B, Lassalle JM, Zajac JM, Frances B (2008). „Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors”. Neuroscience. 157 (1): 12—21. PMID18804517. doi:10.1016/j.neuroscience.2008.08.045.
Cline MA, Mathews DS (2008). „Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands”. General and Comparative Endocrinology. 159 (2-3): 125—9. PMID18823989. doi:10.1016/j.ygcen.2008.09.001.
Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM (2002). „Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists”. Eur. J. Pharmacol. 451 (3): 245—56. PMID12242085. doi:10.1016/S0014-2999(02)02224-0.
Fang Q, Guo J, He F, Peng YL, Chang M, Wang R (2006). „In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist”. Peptides. 27 (9): 2207—13. PMID16762456. doi:10.1016/j.peptides.2006.04.002.
Fang Q, Wang YQ, He F, Guo J, Guo J, Chen Q, Wang R (2008). „Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist”. Regulatory Peptides. 147 (1-3): 45—51. PMID18276024. doi:10.1016/j.regpep.2007.12.007.
Wang YQ, Guo J, Wang SB, Fang Q, He F, Wang R (2008). „Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice”. Peptides. 29 (7): 1183—90. PMID18406009. doi:10.1016/j.peptides.2008.02.016.
nih.gov
ncbi.nlm.nih.gov
Parker RM, Copeland NG, Eyre HJ, Liu M, Gilbert DJ, Crawford J, Couzens M, Sutherland GR, Jenkins NA, Herzog H (2000). „Molecular cloning and characterisation of GPR74 a novel G-protein coupled receptor closest related to the Y-receptor family”. Brain Res. Mol. Brain Res. 77 (2): 199—208. PMID10837915. doi:10.1016/S0169-328X(00)00052-8.
Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Milligan G, Groarke DA, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM (2000). „Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor”. J. Biol. Chem. 275 (34): 25965—71. PMID10851242. doi:10.1074/jbc.M004515200.
Yang HY, Iadarola MJ (2006). „Modulatory roles of the NPFF system in pain mechanisms at the spinal level”. Peptides. 27 (5): 943—52. PMID16443306. doi:10.1016/j.peptides.2005.06.030.
Roumy M, Lorenzo C, Mazères S, Bouchet S, Zajac JM, Mollereau C (2007). „Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity”. The Journal of Biological Chemistry. 282 (11): 8332—42. PMID17224450. doi:10.1074/jbc.M606946200.
Yang HY, Tao T, Iadarola MJ (2008). „Modulatory role of neuropeptide FF system in nociception and opiate analgesia”. Neuropeptides. 42 (1): 1—18. PMID17854890. doi:10.1016/j.npep.2007.06.004.
Betourne A, Familiades J, Lacassagne L, Halley H, Cazales M, Ducommun B, Lassalle JM, Zajac JM, Frances B (2008). „Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors”. Neuroscience. 157 (1): 12—21. PMID18804517. doi:10.1016/j.neuroscience.2008.08.045.
Cline MA, Mathews DS (2008). „Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands”. General and Comparative Endocrinology. 159 (2-3): 125—9. PMID18823989. doi:10.1016/j.ygcen.2008.09.001.
Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM (2002). „Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists”. Eur. J. Pharmacol. 451 (3): 245—56. PMID12242085. doi:10.1016/S0014-2999(02)02224-0.
Fang Q, Guo J, He F, Peng YL, Chang M, Wang R (2006). „In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist”. Peptides. 27 (9): 2207—13. PMID16762456. doi:10.1016/j.peptides.2006.04.002.
Fang Q, Wang YQ, He F, Guo J, Guo J, Chen Q, Wang R (2008). „Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist”. Regulatory Peptides. 147 (1-3): 45—51. PMID18276024. doi:10.1016/j.regpep.2007.12.007.
Wang YQ, Guo J, Wang SB, Fang Q, He F, Wang R (2008). „Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice”. Peptides. 29 (7): 1183—90. PMID18406009. doi:10.1016/j.peptides.2008.02.016.